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Chicago, IllinoisABSTRACT Proper cholesterol transport is essential to healthy cellular activity and any abnormality can lead to several fatal
diseases. However, complete understandings of cholesterol homeostasis in the cell remains elusive, partly due to the wide vari-
ability in reported values for intra- and intermembrane cholesterol transport rates. Here, we used time-resolved small-angle
neutron scattering to measure cholesterol intermembrane exchange and intramembrane flipping rates, in situ, without recourse
to any external fields or compounds. We found significantly slower transport kinetics than reported by previous studies, partic-
ularly for intramembrane flipping where our measured rates are several orders of magnitude slower. We unambiguously demon-
strate that the presence of chemical tags and extraneous compounds employed in traditional kinetic measurements dramatically
affect the system thermodynamics, accelerating cholesterol transport rates by an order of magnitude. To our knowledge, this
work provides new insights into cholesterol transport process disorders, and challenges many of the underlying assumptions
used in most cholesterol transport studies to date.INTRODUCTIONCholesterol is an important structural component of
most cell membranes contributing to their organization,
dynamics, and bending modulus; regulating their interac-
tions with the cytoskeleton; and in some cases controlling
the functions of membrane proteins crucial for several
transmembrane signaling processes (1–3). Healthy cells
maintain a cholesterol gradient along the exocytic path
from the endoplasmic reticulum to the plasma membrane,
with only 0.05% to 1% of the cellular cholesterol residing
in the endoplasmic reticulum, whereas 60–70% resides
in the plasma membrane. It has been suggested that this
cholesterol homeostasis is maintained by the intrinsic ability
of lipid membranes to selectively accept and reject choles-
terol from their surface (2,4). The significance of cholesterol
transport is clear: dysfunction in cholesterol transport leads
to several rare monogenic diseases such as lysosomal choles-
terol-sphingolipid storage diseases, and has even been linked
to severe disorders such as the fatal neurodegenerative
disease Niemann Pick Type-C and Alzheimer’s disease (1).
This essential role of cholesterol trafficking within the
cell has led to numerous studies that aim to understand
and quantify the kinetics of cholesterol transport processes
using model lipid systems (5–13). However, progress in
this area has been hampered by the wide variation in inter-
and intramembrane cholesterol transport rates reported in
the literature (2,14). Indeed, the reported half-life for trans-
membrane cholesterol flipping varies by five to six orders ofSubmitted March 21, 2011, and accepted for publication June 2, 2011.
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0006-3495/11/07/0370/8 $2.00magnitude, ranging from several hours (10–12) to a few
seconds (5,8,9) down to even a few milliseconds (13,15).
On the other hand, the reported half-lives for intermembrane
exchange vary by only an order of magnitude, ranging from
many hours (10) down to tens of minutes (6). These are
often accompanied by the surprising finding that 20–40%
of the cholesterol is nontransferable, indicating that the
cholesterol does not equilibrate completely between vesi-
cles, at least on the time scale of the measurements.
Most studies do not discuss at much length either the
effects of using different systems (exact nature of phospha-
tidylcholines, cholesterol/lipid ratio, concentration, size
of vesicle, doping of phosphatidylcholines with charged
lipids), or the effect of temperature, suggesting that the rates
are not significantly affected. Thus, it is difficult to compare
values from different studies on the same system as it is
impossible to distinguish the effect of varying experimental
parameters from those introduced by the experimental tech-
nique used. However, in at least one case we found that the
reported transmembrane flipping rates for very similar
conditions of cholesterol in red blood cells at 37C, still
differ by a few orders of magnitude from several hours
(16,17) to a few seconds (18,19).
A potential source for these discrepancies is the well-
appreciated limitation that every experimental technique
used to date introduces external fields or compounds, which
must be assumed, but can never be shown, to minimally
affect the rate being measured. Indeed, the reported values
for cholesterol flipping rates between different labeled
cholesterol analogs vary by several orders of magnitude
ranging from seconds to hours (5,10). Similarly, extraneous
compounds such as cyclodextrin and cholesterol oxidase aredoi: 10.1016/j.bpj.2011.06.014
Cholesterol Transport 371often introduced to measure cholesterol flipping rates
assuming that these molecules do not affect the flipping
process (5,8,9,12). A few studies have begun to challenge
this claim (14,16,20), supported in part by the observation
that the measured half-life for cholesterol flipping varies
from hours at low cholesterol oxidase concentrations (12)
to seconds (9) at higher cholesterol-oxidase concentrations.
Finally, most of the studies of cholesterol exchange kinetics
involve mixing cholesterol donor and acceptor vesicles re-
quiring a periodic isolation step to assay the amount of cho-
lesterol exchanged, introducing additional uncertainties (2).
In this study, we circumvent these potential limitations by
using time-resolved small-angle neutron scattering (TR-
SANS) as an in situ probe of cholesterol transfer rates in
the absence of chemical tags or extraneous compounds.
Neutrons scatter through interaction with the nuclei and
are therefore sensitive to the particular isotope used. Thus,
isotopic labeling can be used to hide or highlight different
components in a system or even different parts of molecules.
SANS has been highly successful in the study of soft
condensed matter for over 30 years. In particular, in the
past decade, TR-SANS has been successfully applied to
study the exchange rate of polymer chains between polymer
micelles (21) and more recently to study the residence time
of lipids within a vesicle (22). Here, we extend that tech-
nique to look at the exchange rates of cholesterol in between
vesicles. Interestingly, for the 1-palmitoyl-2-oleoyl-sn-glyc-
ero-3-phosphocholine (POPC) systems studied here we find
that the flipping rates are in general slower than the
exchange rates. By measuring the kinetic rate constants at
several temperatures, we extract the energy of activation
for both the flipping and the exchange processes. We also
demonstrate that even the relatively benign ergosta-
5,7,9(11),22-tetraen-3b-ol (DHE) can dramatically alter
the kinetics. We further show that besides accelerating the
intermembrane exchange rate, the commonly used cyclo-
dextrin for measuring flipping rates actually significantly
affects the intramembrane kinetics. Our results lead us to
question the fundamental driving forces behind cholesterol
transport.MATERIALS AND METHODS
Vesicle preparation
1-Palmitoyl(d31)-2-oleoyl-sn-glycero-3-phosphocholine (dPOPC with one
of the two chains deuterated), cholesterol, dehydroergosterol or DHE,
cholesterol 3-sulfate, and the extruder setup were purchased from AVANTI
POLAR LIPIDS (Alabaster, AL). The lipids were used as received. Small
unilamellar vesicles (SUVs) were prepared by the extrusion method
described elsewhere (23). In short, the desired lipid mixtures were prepared
in powdered form and then dissolved in chloroform. Chloroform was used
to ensure the proper mixing of cholesterol and lipids. The chloroform was
then removed by passing a stream of dry nitrogen over the samples. The
samples were further dried by placing in a vacuum oven overnight at
50C. These mixtures were then hydrated with solvents made of appropriate
ratios of D2O and H2O for the particular contrast desired (see section onContrast Matching below). Finally, these aqueous solutions were extruded
through 100 nm polycarbonate filters to produce the SUVs. To verify
the stability of the vesicles over the temperature and time ranges of these
experiments, SANS patterns from pure vesicle solutions at 60C and
20C were measured over time. The vesicles were stable over three days
in this temperature range.Small-angle neutron scattering
SANS measurements were performed on the NG7 and NG3 30 m SANS
instruments at the National Institute of Standard and Technology (NIST),
Gaithersburg, MD, and on D22 in ILL in Grenoble France. Measurements
were made at a single instrument configuration covering a q-range of
0.003 % q % 0.025 A˚1. Here, q is the scattering vector given by
q ¼ 4p sinðq=2Þ=l, where q is the scattering angle and l is the neutron
wavelength. The wavelength used was 6 A˚. Data were collected using
a 2-D detector and reduced using the reduction package provided by the
NIST (24) and the GRASP package provided by ILL (25). For the kinetic
studies, the reduced intensities were integrated over the whole detector
and plotted and analyzed as a function of time.Contrast matching
To render the lipid vesicles invisible for this study, the scattering length
density (SLD or scattering power) of the vesicles were matched to that of
the solvent by using a mixture of D2O and H2O (D2O and H2O have very
different SLDs). The proper ratio was determined by measuring the
SANS pattern from dPOPC vesicles in varying mixtures of D2O and
H2O. The macroscopic cross section of noninteracting vesicles is given by
Ia nPðQÞV2ðSLDsolvent  SLDvesicleÞ2;
where P(Q) is the form factor of the vesicle, n is the number density of
vesicles, and V the volume of one vesicle. The contrast match point (point
at which the SLD difference equals zero) is obtained by plotting the square
root of the macroscopic cross section versus the volume fraction of D2O.
The match point (point where the cross section goes to zero) was found
to be at a volume fraction of 48.6% D2O/H2O. The contrast match point
was then tested by measuring pure vesicles in a 48.6 volume % D2O solvent
that yielded a completely flat SANS pattern (see Fig. 2 A), indicating that
a near perfect contrast match was achieved. All further experiments in
this study were performed in 48.6% D2O.Cholesterol transfer measurements
To estimate the cholesterol transfer rates, two vesicle populations were
prepared: Donor dPOPC vesicles containing 35 mol % cholesterol and
acceptor dPOPC vesicles without cholesterol. To measure transfer rates
of cholesterol-sulfate and DHE, donor vesicles made of dPOPC/choles-
terol-sulfate (65/35) and dPOPC/DHE (65/35), respectively, were prepared.
Both donor and acceptor vesicle populations were prepared using the 48.6
volume % D2O solvent to contrast match the dPOPC. At t ¼ 0 equal
portions of donor and acceptor vesicle solutions were mixed together and
SANS patterns were measured as a function of time. For each time point,
the scattered intensity was corrected for solvent scattering (by sub-
tracting the scattered intensity from a pure solvent sample) and integrated
over the q range of 0.003 < q < 0.02 A˚1.
To make an unambiguous determination of the scattering intensity at
t ¼ 0, an aliquot of donor vesicles was mixed with an equivalent volume
of pure solvent (i.e., solution devoid of acceptor vesicles). This avoids
any change in intensity between the time of mixing and that of the first
measurement and also serves as a check as to how much of the kinetics
were missed during the time required for mixing, placing in the machine,
and starting the data acquisition.Biophysical Journal 101(2) 370–377
372 Garg et al.The integrated intensity normalized to that at time t¼ 0 is then plotted as
a function of time to produce decay curves (see Fig. 2 B). The scattering
patterns were collected long enough to ensure equilibrium was reached.
A schematic of the process is shown in Fig. 1 A.
The following model was fit to the decay curves thus obtained to extract
the exchange constants and half-lives. Let Cind and Coutd be the cholesterol
concentrations in the inner and outer monolayer of the donor vesicles and
Cina and Couta be the cholesterol concentrations in the inner and outer mono-
layer of the acceptor vesicles. The change in cholesterol concentration in
each monolayer with respect to time can be written as
dCind
dt
¼ Kf ðCind  CoutdÞ; (1)
dCoutd
dt
¼ Kf ðCind  CoutdÞ  KexðCoutd  CoutaÞ; (2)
dCouta
dt
¼ Kf ðCina  CoutaÞ  KexðCouta  CoutdÞ; (3)
dCina
dt
¼ Kf ðCina  CoutaÞ: (4)
At t ¼ 0, cholesterol is only in the donor vesicles. Assuming that at equi-
librium both monolayers contain the same concentration of cholesterol, the
following boundary conditions can be applied.
At t ¼ 0; Cind ¼ Coutd ¼ 0:35 and Cina ¼ Couta ¼ 0:0:
(5)A
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FIGURE 1 (A) Schematic of experimental protocol: Donor and acceptor vesic
rendering them invisible to neutrons. At t ¼ 0, only the donor vesicles are visibl
cholesterol moves from donor to acceptor vesicle, the acceptor vesicles gradually
of the donor and acceptor vesicles as a function of time assuming cholesterol exc
bution to the normalized intensity from the donor and acceptor vesicles as a funct
curves illustrating the relative effects of Kex and Kf on the decay curves.
Biophysical Journal 101(2) 370–377The scattering intensity of a dilute solution containing donor and
acceptor vesicles is given by Eq. 6 where nd, na are the number density
of donor and acceptor vesicles, Vd, Va are the volume of one donor and
one acceptor vesicle, respectively, and P(Q) is the form factor for a single
vesicle.
Ia ndPðQÞdV2dðSLDd  SLDsolventÞ2þnaPðQÞaV2a
ðSLDa  SLDsolventÞ2:
(6)
The scattering length density of cholesterol containing vesicles can be
computed as
SLDvesicle ¼

FcholSLDchol þFlipidSLDlipid

 Fchol þFlipid

: (7)
Here, Fchol, Flipid are the volume fraction of cholesterol and lipid in each
vesicle. Solving Eq. 6 and Eq. 7 with the added condition that SLDsolvent ¼
SLDlipid (since the lipid is contrast matched to the solvent), leads to the
following simplified equation.
Iað1 xÞ2þðxÞ2; (8)
where x is the cholesterol fraction that has exchanged and is given by
x ¼ ðCina þ CoutaÞ=ðCind ;t¼ 0 þ Coutd ;t¼ 0Þ: (9)
At t ¼ 0, x ¼ 0. These equations were implemented in IGOR and used to
fit the experimental data to obtain the exchange rates.D1.0
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Cholesterol Transport 373Simulated curves for the cholesterol fraction in the inner and outer mono-
layers of donor and acceptor vesicles as a function of time are given in
Fig. 1 B. Because the intensity is proportional to the square of the choles-
terol fraction in the vesicle, a 50% decrease in cholesterol concentration in
the donor vesicle, leads to a drop of 75% in the scattered intensity from the
original (t ¼ 0) donor vesicles as shown in Fig. 1 C. Similarly, the increase
in scattered intensity from the acceptor vesicles, which have received the
cholesterol, will be only 25% of the scattered intensity of the original
(t¼ 0) donor vesicles. This leads to a net decrease in total normalized solu-
tion intensity from 1 to 0.5 if cholesterol fully equilibrates between donor
and acceptor vesicles. It is interesting to note the consequences of the set of
differential equations and boundary conditions used to extract the two rate
constants from the raw decay curves. In particular, it means that only Kex
contributes close to t ¼ 0 whereas, if Kf is sufficiently slow to limit the
exchange, it will dominate at long times as illustrated in Fig. 1 D.RESULTS
In this study, we use a 40 mg/ml lipid system (~0.04 lipid
volume fraction) of 100 nm POPC vesicles as the model
membrane. The experiment is illustrated schematically in
Fig. 1. Hydrogen/deuterium substitution in the lipid and the
solvent is used to render the vesicles completely invisible.
Only the cholesterol, dispersed within the invisible vesicle
membrane, is highlighted. Two populations of identically
sized invisible vesicles are prepared: one contains cholesterol
that serves as the donor population, while the other contains
no cholesterol and serves as the acceptor population. A
0.35 mol fraction of cholesterol/lipid ratio is used in the
donor population to roughly mimic the cholesterol content
of cell membranes. The two populations are mixed in equal
amounts at time t ¼ 0 and the total scattered intensity is
followed as a function of time to quantitatively track the
redistribution of cholesterol betweenvesicles. This technique
relies on the fact that for a fixed particle shape, the total scat-
tering depends on the square of the contrast between the
particle and the solvent (and in this case the contrast is justBA
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FIGURE 2 (A) Scattering curves for a sample with donor (cholesterolþ dPOP
and t ¼ 600 min (open blue squares) showing that the vesicle size and shape rem
the data. The open green triangle data are for a pure system of (dPOPC) and show
bars represent5 s as propagated from the counting statistics of the experiment.
55C data has been omitted for clarity), with corresponding fits, showing the tem
Arrhenius fits for flipping and exchange rates. Note that some error bars are large
used in the regression appropriately weighted for their uncertainty.proportional to the volume fraction of cholesterol in the
vesicle) and only linearly with the number density of parti-
cles (which increases by a factor of two as the acceptor
vesicles, initially invisible, begin to scatter from the choles-
terol that migrates to them). The net effect is that after
complete exchange, the total intensity should drop by a factor
of two, whereas the shape of the curve should remain
unchanged. Thus, a plot of the total scattered intensity (inte-
grated over a wide q range), normalized to the total intensity
at time t ¼ 0, will drop from 1 at t¼ 0, to 0.5 after complete
exchange (t ¼ infinity) as shown schematically in Fig. 1 C.
The success of this quantitative approach relies on two
critical assumptions: that the pure lipid vesicles are invisible
and that the integrity of the vesicles is maintained through
the entire cholesterol transfer process. The data in Fig. 2 A
demonstrate the validity of these assumptions, showing no
scattering above background for our pure dPOPC. Simple
visual inspection of the data for the cholesterol donor/
acceptor system, at 50C, at time t ¼ 0 and t ¼ 600 min
(10 h) indicates the two curves are identical except for being
offset by a factor of two, demonstrating that the vesicles do
not change during the course of the exchange. A vesicle
form factor fits both curves with the parameters correspond-
ing to cholesterol decorated vesicles. Lack of any modula-
tion to the vesicle form factor suggests that cholesterol is
homogeneously distributed throughout each vesicle rather
than forming domains. Furthermore, as shown in Fig. 2 B,
the normalized intensity decay curves asymptote to 0.5, cor-
responding to an equal distribution of cholesterol between
donor and acceptor vesicles at equilibrium. It is interesting
to note that this result is at odds with some previous obser-
vations, which suggest that up to 40% of the cholesterol is
not transferable from donor to acceptor vesicles in POPC
systems, at least in the 24C to 37C temperature range
(6,26). However, the present results are consistent with other-11
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374 Garg et al.reports that do not find such nontransferable cholesterol
(10,27–29) and with the long held understanding that
cholesterol does not have specific interactions with unsatu-
rated lipids, such as POPC, and thus does not form clusters
or complexes with them.
Although the normalized intensity decay data of Fig. 2 B
can be modeled as a single decay process, the fit is not very
satisfactory and a two-process model provides a much better
description of the data. As is typically done for these
systems, two pools of cholesterol are considered: one in
the inner monolayer and the other in the outer monolayer.
Cholesterol in the outer monolayer is directly available for
exchange, whereas cholesterol in the inner monolayer can
only exchange after flipping to the outer monolayer thereby
limiting the exchange rates. If the flipping rate is very fast
compared to the exchange rate one would only measure
one decay process. However, if it is much slower, the
cholesterol in the outer monolayer will deplete before that
in the inner monolayer can replenish the reservoir leading
to two distinct decay times. Modeling the data as the result
of two kinetic processes leads to a set of differential equa-
tions, which can be solved to yield two effective rate
constants, Kf and Kex, that describe the rate at which the
cholesterol molecules flip from the inner to the outer mono-
layer and the rate at which they exchange between two sepa-
rate vesicles, respectively (see Materials and Methods
for details). This is shown schematically in Fig. 1 B for
Kex ¼ Kf ¼ 0.01 min1. Applying the above analysis to
the experimental data of Fig. 2 B leads to excellent fits of
the decay curves. The results are given in Table 1.
To extract the energetics of the system, we performed the
same experiment at three other temperatures: 40C, 55C,
and 60C. The temperature-dependent rate constants were
plotted as an Arrhenius function in Fig. 2 C. For the POPC
model membrane system used in this study, we measured
an enthalpy of activation of 87 5 14 kJ/mol for flipping
and 101 5 5 kJ/mol for exchange. This leads to a couple
of observations. The first is that the temperature dependence
of the rates seems more significant than one might infer from
the existing literature (7,30,31). The second is that the acti-
vation energy for flipping is similar to that of exchange.
This last is somewhat surprising as the relatively small
hydrophilic moiety on the cholesterol, coupled with an
extremely low solubility in aqueous medium of a few nano-
molar, has led to the widely held belief that flipping would
be much easier than exchange (8,32).TABLE 1 Intra- and intermembrane diffusion rates and half-lives fo
Kf (min
1)
Cholesterol 0.00355 0.0002
Cholesterol-sulfate 0.00385 0.0005
DHE 0.035 0.01
Cholesterol with b-cyclodextrin 0215 0.002
Cholesterol measurement was repeated three times and the weighted averages a
Biophysical Journal 101(2) 370–377To further probe the validity of this two-process model,
cholesterol was replaced with cholesterol sulfate. The
cholesterol-sulfate molecule is structurally very similar to
cholesterol, but the sulfate group makes the headgroup far
more hydrophilic. Thus, the flipping rate, requiring the
hydrophilic headgroup to transit through the lipidic interior
of the membrane, should be significantly slowed, while the
exchange rate, requiring the molecule to transit through the
aqueous phase, would be expected to increase, allowing us
to more rigorously decouple the exchange and flipping
processes. The decay curve for cholesterol-sulfate in POPC
vesicles at 50C is shown in Fig. 3 A. It is immediately clear
that there are two very distinct decays. The breakpoint in the
decay curve occurs after 11 5 0.5 min with a normalized
intensity of 0.625 5 0.025, whereas the very slow decay
requires nearly 17 h to achieve the equilibrium value of
0.5. The breakpoint value of 0.625 means exactly 25% of
the cholesterol is transferred from the donor to the acceptor
vesicles in the first process. This further supports our simple
two step model in which the 50% of the cholesterol in the
outer monolayer of the donor vesicles fully equilibrates
between vesicle populations long before the 50% in the inner
monolayer can flip to the outer monolayer and thus become
available to participate in the exchange.
Time-resolved SANS offers the versatility to measure
tagged and untagged molecules alike, and therefore, it is
possible to begin addressing questions concerning possible
artifacts in reported flipping and exchange kinetics due to
the necessity, using most current methodologies, of inferring
the cholesterol transport properties from those of chemically
altered cholesterol, or by use of extraneous compounds that
may alter the energetics of the system.
First, we looked at the effect of using DHE as a cholesterol
mimic. DHE is an extensively used self-fluorescent choles-
terol analog due to its similarities to cholesterol in structure,
organization, and dynamics (7,33). Indeed, it has been shown
that DHE exhibits a similar segregation behavior to choles-
terol when residing in lipid membranes (34) and that its
distribution within cells is the same as that of cholesterol
(35,36). In addition, several studies have suggested that the
transport properties of DHE are similar to those of choles-
terol based on comparisons of transport properties of DHE
and tritium-labeled cholesterol (radio-labeled) (5,6,35). For
this experiment, we replaced cholesterol with DHE while
keeping the above sample preparation and protocols iden-
tical. Fig. 3 B compares the normalized intensity decayr cholesterol transport in POPC vesicles at 50C
T1/2_f (min) Kex (min
1) T1/2_ex (min)
2005 13 0.00795 0.0002 88 5 2
1825 25 0.155 0.03 4.6 5 0.8
22 5 7 0.0335 0.003 21 5 2
33 5 3 0.0555 0.003 12.55 0.6
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Cholesterol Transport 375curves for DHE and cholesterol at 50C. These data show
that both the flipping and exchange rates for DHE are
much faster than for cholesterol. The fitted half-life for
DHE exchange at 50C is 21 5 2 min compared to 88 5
2 min for true cholesterol. Likewise, the flipping half-life
for DHE at that temperature is measured to be 225 7 min
as compared to 2005 13 min for cholesterol. These signif-
icant differences lead us to question the use of DHE as
a cholesterol mimic for studies of cholesterol transport.
To study the effect of extraneous components we chose
cyclodextrin. Cyclodextrin is commonly used in measure-
ments aimed at estimating the intramembrane cholesterol
flipping rates. This molecule is known to alter the intermem-
brane exchange rate by increasing the cholesterol solubility
in the aqueous medium, but the argument is made that it does
not affect the inner monolayer and therefore does not affect
the flipping (5,8,9,12,19,37,38). To test the assumption that
cholesterol transmembrane flipping is not affected by pres-
ence of cyclodextrin, we repeated the previous cholesterol
transport measurements in the presence of 2 mM cyclodex-
trin, a concentration consistent with that used in cholesterol
flipping studies. The data are shown in Fig. 3C. As expected,
the intermembrane exchange rate of the cholesterol in-
creases significantly, in agreement with previously reported
results (8). The flipping rate however also increases by an
order of magnitude. As reported in Table 1, the presence of
cyclodextrin dropped the half-life for cholesterol flipping
from 200 5 13 min to 33 5 3 min. This result clearly
puts into question the assumptions underlying the use of
cyclodextrin for the accurate measurement of cholesterol
flipping kinetics and suggests that care should be taken in in-
terpreting those results.DISCUSSION
Our data, using noninvasive in situ measurements, clearly
challenge many of the assumptions made in previous studies
and more generally highlight the difficulty in using chemical
tags or additives to understand the transport properties and
energetic of self-assembled systems. Furthermore, this
work establishes time-resolved SANS as a powerful tool
for elucidating the myriad of contributions to the kinetics
of these complex and interacting systems.One of the more surprising results of this study is the rela-
tively high energy barrier for cholesterol transmembrane
flipping, with an activation energy similar to that for choles-
terol exchange and a flipping half-life of a few hours. The
largest reported activation energy we are aware of is only
half the activation energy measured here (30,31), several
older studies have reported cholesterol flipping times of
a few hours (10–12) for a wide variety of lipid membrane
compositions and temperatures, there are numerous more
recent reports suggesting that cholesterol can flip within a
few seconds or even milliseconds (5,8,13,15). These latter
values are supported by recent molecular dynamic simula-
tions (32) and are more consistent with the simple molec-
ular picture of cholesterol as mostly hydrophobic with a
small hydrophilic moiety. Cholesterol would therefore flip
easily within the hydrophobic membrane while exchanging
slowly between membranes due to the extremely low solu-
bility in aqueous medium of a few nanomolar (8,32). This
simple picture is however clearly at odds with our data.
Moreover, the cholesterol-sulfate system presented in this
work, while dramatically decreasing the energy barrier to
exchange, as expected, did not significantly alter the trans-
membrane flipping time. Combined, these observations
suggest that, at least in this POPC system, the mechanism
for cholesterol flipping between the inner and outer mono-
layer may not be dominated by hydrophobic/hydrophilic
interactions between the lipids and cholesterol. Other
drivers might include cholesterol-lipid steric interactions,
the energetics of lipid tail packing, and even Van der Waals
interactions.
The dramatic effect on cholesterol transfer rates origi-
nating from such apparently innocuous actions as the addi-
tion of small amounts of cyclodextrin or the substitution of
chemically tagged cholesterol, allows us to both reconcile
our results with the existing literature and indeed begins to
explain the wide variability in those reported values. More-
over, the upper limit on reported life times for exchange
seems to be in the hour’s regime, which is close to what
we observe at 50C. Lower temperatures, where most of
the reported values are measured, would have much longer
lifetimes, of perhaps even days rather than hours. A possible
explanation for the discrepancy is that after several hours it
becomes hard to discern any change in cholesterolBiophysical Journal 101(2) 370–377
376 Garg et al.distribution over the course of the experimental sampling
times, which may lead to an erroneous conclusion that the
experiment has reached equilibrium. Besides explaining
the relatively weak temperature dependence found in
previous studies, such a hypothesis would also explain the
surprising reports of nontransferable cholesterol, since the
time reported would, in fact, be far from the true equilibra-
tion time. In fact, at least one study found that the amount
of nonexchangeable cholesterol decreases with time (27),
strongly supporting the idea that the observation of nonex-
changeable cholesterol may just be the signature of a very
slow kinetic process. This would eliminate the thermody-
namic conundrum of having to explain how a fraction of
the cholesterol becomes stuck in a lipid system such as
POPC, which, unlike saturated lipids, is thought to have no
specific interactions with cholesterol. Complete exchange
was observed for all systems studied here (cholesterol,
cholesterol-sulfate, DHE, and cholesterol þ cyclodextrin).
Certainly, the cell membrane is a rich and complex envi-
ronment and it is easy to see, given this exquisite sensitivity
of cholesterol transport to the details of that environment,
how organisms might be able to very finely tune the choles-
terol balance within their cellular structures. Furthermore,
the slower cholesterol flipping rates detailed in this work
provide a clear path to explaining the higher cholesterol
concentration in the cytoplasmic leaflet over that in the
extracellular leaflet. Lipid-cholesterol interactions alone
cannot generate such an asymmetry as unsaturated lipids,
more prevalent in the cytoplasmic leaflet, which show
much lower affinity for cholesterol than the saturated lipids
present in the extracellular leaflet of the bilayer. The sugges-
tion that this cholesterol asymmetry is regulated by trans-
porter proteins on the other hand (and in fact any active
pumping mechanism) is only reasonable if cholesterol trans-
membrane flipping rates are relatively slow.
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